13 Atopic Dermatitis Clinical Trials in Madison, WI (2026)

Q: How do I join a clinical trial in Madison?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you.

Recruiting Atopic Dermatitis Studies in Madison

NCT07635095Recruiting

A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants

The goal of this clinical trial is to compare two different presentations (vial and syringe versus autoinjector) of navenibart in healthy adult volunteers. The main questions it aims to answer are: *...

Madison, WIPHASE1180 participantsAstria Therapeutics, Inc.

View Study Details

NCT06598800Recruiting

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

This is a first-in-human (FIH), Phase 1a/1b, open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and prelim...

Madison, WIPHASE1153 participantsBeOne Medicines

View Study Details

NCT03945162Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with NMIBC CIS (with or without resected papillary disease (Ta, T1)) that are conside...

Madison, WIPHASE290 participantsTheralase® Technologies Inc.

View Study Details

NCT06504160Recruiting

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatm...

Madison, WIPHASE186 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05521698Recruiting

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

This phase I trial evaluates the effects of bicalutamide, compared to no study drug (NSD), on epidermal growth factor receptor (EGFR) protein expression in patients with non-muscle invasive bladder ca...

Madison, WIPHASE180 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06730347Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Study CP-MGD019-03 is an open-label study of lorigerlimab in participants with platinum-resistant ovarian cancer (PROC) or clear cell gynecologic cancer (CCGC). Approximately 60 participants will be e...

Madison, WIPHASE280 participantsMacroGenics

View Study Details

NCT05798897Recruiting

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

This study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starti...

Madison, WIPHASE179 participantsMarker Therapeutics, Inc.

View Study Details

NCT06975657Recruiting

Well-being Skills for Reentry

The goal of this clinical trial is to learn if a mindfulness skills training program has mental health benefits for people returning to the community following incarceration. The main questions it aim...

Madison, WINA60 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06557733Recruiting

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

This open-label phase II trial tests how well TPST-1495 works in reducing the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is an inherited c...

Madison, WIPHASE238 participantsNational Cancer Institute (NCI)

View Study Details

NCT07048457Recruiting

Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma

This study investigates the therapeutic benefit of consolidative local therapy with extirpative surgery for participants with locally advanced or oligo-metastatic urothelial carcinoma that have diseas...

Madison, WIPHASE232 participantsYale University

View Study Details

NCT07498270Recruiting

Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep

This study is to find out whether a type of non-invasive electrical brain stimulation called temporal interference transcranial electrical stimulation (TI-TES) can temporarily change brain activity du...

Madison, WINA24 participantsUniversity of Wisconsin, Madison

View Study Details

NCT05334004Recruiting

Lopinavir/Ritonavir in PLWH With High-Grade AIN

This study is being done to assess the safety of lopinavir/ritonavir in patients with PLWH with AIN. 30 participants will be recruited and can expect to be on active study for approximately 3 months a...

Madison, WIPHASE121 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06940440Recruiting

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

This Phase 1, multicenter, open-label trial will assess the safety and feasibility of IFx-Hu2.0 as adjunctive therapy to pembrolizumab in adult patients (≥18 years) with non-cutaneous Merkel Cell Carc...

Madison, WIPHASE19 participantsTuHURA Biosciences, Inc.

View Study Details

About Atopic Dermatitis Clinical Trials in Madison

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 13 atopic dermatitis clinical trials recruiting participants in Madison, WI. These studies are seeking a combined 932 participants. Research is being sponsored by Astria Therapeutics, Inc., BeOne Medicines, Theralase® Technologies Inc. and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Madison — FAQ

Are there atopic dermatitis clinical trials in Madison?

Yes, there are 13 atopic dermatitis clinical trials currently recruiting in Madison, WI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Madison?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you about next steps.

Are clinical trials in Madison free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madison studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 13 active trials in Madison are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated October 18, 2026 from ClinicalTrials.gov